To verify whether circLIFR exerts tumor-suppressive effects via the circLIFR/miR-624-5p/GSK-3β axis, we performed rescue assays to assess whether GSK-3β could reverse the cellular functions of circLIFR in HCC. This evidence concerns the gene GSK3B and hepatocellular carcinoma.